Literature DB >> 12855267

A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol.

J Buwalda1, P F Schouwenburg, L E C M Blank, J H M Merks, M P Copper, S D Strackee, P A Voûte, H N Caron.   

Abstract

The AMORE protocol is a local treatment regimen for head and neck rhabdomyosarcomas (HNRMS), consisting of Ablative surgery, Moulage technique brachytherapy and surgical Reconstruction. The aim of AMORE is to intensify local treatment for children with HNRMS and to avoid external beam radiation therapy (EBRT) and its long-term sequelae. All children with primary irresectable, non-orbital HNRMS in whom EBRT was indicated, were evaluated for the feasibility of AMORE. In 20 children, AMORE was performed (15 with parameningeal disease and five with non-parameningeal disease). Complete remission was achieved in all 20 patients. Local complications were limited. 5 patients experienced a local relapse and 1 patient developed distant metastases. Estimated 5-year OS and EFS were 67.5 and 64.1% for the entire group, and 64.2 and 60.0% for the parameningeal subgroup. We conclude that the AMORE protocol is a feasible strategy, with a good local control rate. Long-term sequelae of EBRT might be avoided although, to date, the follow-up is too short for definitive conclusions regarding these sequelae.

Entities:  

Mesh:

Year:  2003        PMID: 12855267     DOI: 10.1016/s0959-8049(03)00363-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  Orbital rhabdomyosarcomas: A review.

Authors:  Lama Jurdy; Johanus H M Merks; Bradly R Pieters; Maarten P Mourits; Roel J H M Kloos; Simone D Strackee; Peerooz Saeed
Journal:  Saudi J Ophthalmol       Date:  2013-07

2.  Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.

Authors:  J H M Merks; G L De Salvo; C Bergeron; G Bisogno; A De Paoli; A Ferrari; A Rey; O Oberlin; M C G Stevens; A Kelsey; J Michalski; D S Hawkins; J R Anderson
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

3.  Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.

Authors:  Rainer Joachim Strege; György Kovács; Jens Eduard Meyer; Detlef Holland; Alexander Claviez; Maximilian H Mehdorn
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

4.  Imaging findings in craniofacial childhood rhabdomyosarcoma.

Authors:  Nicole J M Freling; Johannes H M Merks; Peerooz Saeed; Alfons J M Balm; Johannes Bras; Bradley R Pieters; Judit A Adam; Rick R van Rijn
Journal:  Pediatr Radiol       Date:  2010-08-20

Review 5.  The role of radiology in paediatric soft tissue sarcomas.

Authors:  K Park; R van Rijn; K McHugh
Journal:  Cancer Imaging       Date:  2008-04-22       Impact factor: 3.909

Review 6.  An overview of radiological manifestations of acquired dental developmental disturbances in paediatric head and neck cancer survivors.

Authors:  Reinier C Hoogeveen; Marinka L F Hol; Bradley R Pieters; Brian V Balgobind; Erwin W E R Berkhout; Reineke A Schoot; Ludi E Smeele; Hans J H M Merks; Eddy A G Becking
Journal:  Dentomaxillofac Radiol       Date:  2019-11-18       Impact factor: 2.419

7.  Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma.

Authors:  Stephanie E Combs; Wolfgang Behnisch; Andreas E Kulozik; Peter E Huber; Jürgen Debus; Daniela Schulz-Ertner
Journal:  BMC Cancer       Date:  2007-09-13       Impact factor: 4.430

Review 8.  Imaging findings in noncraniofacial childhood rhabdomyosarcoma.

Authors:  Rick R Van Rijn; Jim C H Wilde; Johannes Bras; Foppe Oldenburger; Kieran M C McHugh; Johannes H M Merks
Journal:  Pediatr Radiol       Date:  2008-03-07

9.  Interstitial brachytherapy for orbital soft tissue sarcoma: an innovative technique.

Authors:  Siddhartha Laskar; Avinash Pilar; Nehal Khanna; Yogesh Ghadi
Journal:  J Contemp Brachytherapy       Date:  2017-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.